Short-term [tmco]
Hormone replacement therapy [topp]
Reduced [qlco]
Plasma [bdsu]
soluble [celc]
Adhesion Molecule [aapp, bacs]
Epidemiological [bmod]
Suggest [idcn]
Hormone replacement therapy [topp]
Decreased [qnco]
Cardiovascular disease [dsyn]
Endothelium, Vascular [tisu]
Adhesion Molecule [aapp, bacs]
Play [dora]
Initiation [menp]
progression [patf]
Atherosclerosis [dsyn]
Material [sbst]
Methods [inpr]
prospective [resa]
randomized [resa]
placebo controlled study [inpr, resa]
Health [idcn]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Received [qlco]
Estradiol 2 MG [clnd]
Alone [qnco]
N NOS [aapp, imft]
Group [idcn]
Combined [qlco]
Progestagen [horm, phsu, strd]
E-2-P [orch, phsu]
Group [idcn]
trimegestone [orch, phsu]
mg% [qnco]
N NOS [aapp, imft]
Dydrogesterone 10 MG [clnd]
Group [idcn]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
Collected [idcn]
baseline [bodm]
weeks [tmco]
Twelve [qnco]
weeks [tmco]
treatment [ftcn]
E-2-P [orch, phsu]
Decrease [qlco]
plasma concentration [qnco]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
Vascular Cell Adhesion Molecule-1 [aapp, imft]
Thrombomodulin [aapp, rcpt]
STM [lbpr]
Average [qnco]
Decrease [qlco]
Marker [clna]
Women [popg]
treated [topp]
trimegestone [orch, phsu]
decreases [qnco]
larger [qnco]
treated [topp]
Dydrogesterone [horm, phsu, strd]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
STM [lbpr]
P NOS [aapp, imft]
Plasma [bdsu]
Endothelin-1 [aapp, bacs]
Decreased [qnco]
Women [popg]
treated [topp]
E-2-P [orch, phsu]
Group [idcn]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Vasodilatation [phsf]
Increased [qnco]
Percentage [qnco]
Point [qnco]
weeks [tmco]
P NOS [aapp, imft]
baseline [bodm]
P NOS [aapp, imft]
E-2-P [orch, phsu]
P NOS [aapp, imft]
placebo [topp]
Short-term [tmco]
treatment [ftcn]
trimegestone [orch, phsu]
Plasma [bdsu]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
STM [lbpr]
Endothelin-1 [aapp, bacs]
Decreased [qnco]
E-2-P [orch, phsu]
Group [idcn]
Types [qlco]
Progestagens [horm, phsu, strd]
Affect [menp]
soluble [celc]
Intercellular adhesion molecule 1 [aapp, imft]
STM [lbpr]
Levels [qlco]
Relevant [qlco]
choice [inbe]
Hormone replacement therapy [topp]
